Trial for kidney damage in diabetes withdrawn before starting
Disease control
Terminated
This study aimed to test the safety and effectiveness of an experimental intravenous drug called VAR200 for adults with type 2 diabetes and kidney damage. The goal was to see if the drug could reduce the amount of protein leaking into the urine, a key sign of kidney injury, over …
Phase: PHASE2 • Sponsor: ZyVersa Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC